OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q2 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,174,659 | -33.1% | 1,011,038 | +9.9% | 0.00% | -50.0% |
Q2 2023 | $4,745,146 | +466482.7% | 919,602 | +376.4% | 0.00% | – |
Q1 2023 | $1,017 | +71.2% | 193,033 | -8.6% | 0.00% | – |
Q4 2022 | $594 | -99.9% | 211,160 | -17.9% | 0.00% | – |
Q3 2022 | $1,068,000 | -23.7% | 257,262 | -26.1% | 0.00% | -100.0% |
Q2 2022 | $1,399,000 | -16.3% | 348,097 | +6.2% | 0.00% | 0.0% |
Q1 2022 | $1,672,000 | -31.0% | 327,819 | -15.8% | 0.00% | 0.0% |
Q4 2021 | $2,423,000 | -30.1% | 389,548 | +18.6% | 0.00% | 0.0% |
Q3 2021 | $3,466,000 | -6.2% | 328,520 | +26.0% | 0.00% | 0.0% |
Q2 2021 | $3,697,000 | -11.6% | 260,708 | +2.3% | 0.00% | 0.0% |
Q1 2021 | $4,184,000 | -66.4% | 254,951 | -57.6% | 0.00% | -75.0% |
Q4 2020 | $12,434,000 | +562.1% | 600,671 | +143.5% | 0.00% | +300.0% |
Q3 2020 | $1,878,000 | +3.3% | 246,722 | +13.1% | 0.00% | 0.0% |
Q2 2020 | $1,818,000 | +159.3% | 218,234 | +54.0% | 0.00% | – |
Q1 2020 | $701,000 | +33.0% | 141,749 | +6.2% | 0.00% | – |
Q4 2019 | $527,000 | -9.6% | 133,488 | -30.4% | 0.00% | – |
Q3 2019 | $583,000 | +4.9% | 191,831 | +51.9% | 0.00% | – |
Q2 2019 | $556,000 | – | 126,290 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |